SELZENTRY is a Oral Tablet, Film Coated in the Human Prescription Drug category. It is labeled and distributed by A-s Medication Solutions. The primary component is Maraviroc.
| Product ID | 50090-1486_074b036c-dfce-4827-9586-2d67f95891b2 |
| NDC | 50090-1486 |
| Product Type | Human Prescription Drug |
| Proprietary Name | SELZENTRY |
| Generic Name | Maraviroc |
| Dosage Form | Tablet, Film Coated |
| Route of Administration | ORAL |
| Marketing Start Date | 2011-05-16 |
| Marketing Category | NDA / NDA |
| Application Number | NDA022128 |
| Labeler Name | A-S Medication Solutions |
| Substance Name | MARAVIROC |
| Active Ingredient Strength | 300 mg/1 |
| Pharm Classes | CCR5 Co-receptor Antagonist [EPC],Chemokine Co-receptor 5 Antagonists [MoA] |
| NDC Exclude Flag | N |
| Listing Certified Through | 2019-12-31 |
| Marketing Start Date | 2014-12-03 |
| NDC Exclude Flag | N |
| Sample Package? | N |
| Marketing Category | NDA |
| Application Number | NDA022128 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Marketing Start Date | 2014-12-03 |
| Marketing End Date | 2019-10-31 |
| Ingredient | Strength |
|---|---|
| MARAVIROC | 300 mg/1 |
| SPL SET ID: | e6f47a2b-98e8-4c16-9f41-72dfe2fd5389 |
| Manufacturer | |
| UNII | |
| RxNorm Concept Unique ID - RxCUI |
| NDC | Brand Name | Generic Name |
|---|---|---|
| 49702-223 | SELZENTRY | maraviroc |
| 49702-224 | SELZENTRY | maraviroc |
| 49702-233 | SELZENTRY | maraviroc |
| 49702-235 | SELZENTRY | maraviroc |
| 49702-237 | SELZENTRY | maraviroc |
| 49702-260 | SELZENTRY | maraviroc |
| 50090-1486 | SELZENTRY | maraviroc |
| 50090-6238 | SELZENTRY | maraviroc |
| 31722-579 | Maraviroc | Maraviroc |
| 31722-580 | Maraviroc | Maraviroc |
Mark Image Registration | Serial | Company Trademark Application Date |
|---|---|
![]() SELZENTRY 77183318 3372315 Live/Registered |
PHIVCO-1 LLC 2007-05-17 |